Gerrit Grau is currently the EU QPPV at Eli Lilly and Company, where they have been since 2019. Previously, they served as a Senior Medical Advisor Global Patient Safety for Oncology at Eli Lilly from 2013 to 2018, and as Associate VP Global Patient Safety Oncology at ImClone Systems from 2009 to 2012. Gerrit’s extensive experience in the pharmaceutical industry includes roles as a Senior Medical Advisor at Boehringer Ingelheim and various positions at Pfizer GmbH from 1991 to 2008. They earned their medical degree from the Rheinische Friedrich-Wilhelms-Universität in Bonn, completing their studies from 1981 to 1988.
This person is not in the org chart
This person is not in any teams
This person is not in any offices